EASL Congress 2026

Event description:

Novotech will be attending EASL Congress 2026 in Barcelona to connect with biotech and pharmaceutical sponsors advancing liver disease and hepatology programs.

Meet with our experts to discuss strategic and operational considerations for hepatology clinical trials, including feasibility, country and site strategy, start-up planning, patient recruitment, and global study delivery across APAC, North America, and Europe.

With deep regional expertise and a client-focused partnership approach, Novotech helps sponsors navigate the complexities of global clinical development and accelerate trial execution.

Novotech Attendees:

• Dr. Yooni Kim, Chief Customer Experience Officer (CXO)
• Christine Mohlberg, Head of Project Management Infectious Disease
• Tom Hickey, Director Therapeutic Strategy
• Thani Pavlidou, Business Development Director
• Michelle Smith, Project Oversight Director

Attending EASL Congress 2026? Connect with the Novotech team by submitting the meeting request form on this page.